Nasdaq Welcomes Moderna, Inc. (Nasdaq: MRNA) to The Nasdaq Stock Market
December 07 2018 - 1:54PM
Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology
company pioneering messenger RNA (mRNA) therapeutics and vaccines
to create a new generation of transformative medicines for
patients, visited the Nasdaq MarketSite in Times Square today in
celebration of its initial public offering (IPO) on the Nasdaq
Stock Market.
Moderna is a leader in the development of mRNA
medicines, a new class of drugs that directs the body’s cells to
produce proteins that have the potential to prevent, treat or cure
disease. The company has a pipeline of 21 development candidates,
including 10 programs currently in clinical trials. These programs
span diverse areas such as cancer, infectious disease,
cardiovascular disease and rare genetic disorders. Moderna has both
solely controlled programs and strategic collaborations with
leading pharmaceutical companies including AstraZeneca and Merck,
global non-profit organizations and government agencies.
“We believe this milestone will further enable us to advance our
pipeline of investigational mRNA medicines to improve the lives of
people with serious diseases,” said Stéphane Bancel, Chief
Executive Officer of Moderna. “We set out to build a platform that
would enable us to optimize the full potential of mRNA and develop
novel vaccines and therapies. I am proud of our team and their
relentless drive to expand the frontiers of mRNA science and create
a potential new category of medicines for patients.”
“Moderna’s deep commitment to mRNA discovery, research and
development, supported by its team of world-class scientists and
researchers and its state-of the art technology platform and
infrastructure, sets them apart as an industry leader within the
biotechnology sector,” said Nelson Griggs, President, Nasdaq Stock
Exchange. “We are excited to welcome Moderna to the Nasdaq Stock
Exchange and look forward to supporting the company’s commitment to
developing transformative medicines for patients around the
world.”
The information contained above is provided for informational
and educational purposes only, and nothing contained herein should
be construed as investment advice, either on behalf of a particular
security or an overall investment strategy. Information about the
company is provided by the company or comes from the company’s
public filings and is not independently verified by Nasdaq. Neither
Nasdaq nor any of its affiliates makes any recommendation to buy or
sell any security or any representation about the financial
condition of any company. Statements regarding Nasdaq-listed
companies are not guarantees of future performance. Actual results
may differ materially from those expressed or implied. Past
performance is not indicative of future results. Investors should
undertake their own due diligence and carefully evaluate companies
before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY
ADVISED.
About NasdaqNasdaq (Nasdaq: NDAQ) is a leading
global provider of trading, clearing, exchange technology, listing,
information and public company services. Through its diverse
portfolio of solutions, Nasdaq enables customers to plan, optimize
and execute their business vision with confidence, using proven
technologies that provide transparency and insight for navigating
today’s global capital markets. As the creator of the world’s first
electronic stock market, its technology powers more than 100
marketplaces in 50 countries, and 1 in 10 of the world’s securities
transactions. Nasdaq is home to approximately 4,000 total listings
with a market value of approximately $14 trillion. To learn more,
visit: http://business.nasdaq.com
MEDIA RELATIONS CONTACT:
Emily Pan(646)
441-5120 emily.pan@nasdaq.com
NDAQG
A photo accompanying this announcement is available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/63bc1237-3bf3-4ac4-99b0-6c07b738e939
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From Apr 2023 to Apr 2024